Role of Clinical Informatics During the COVID-19 Pandemic

With REMISOL Advance, labs can integrate results from cross-functional platforms to get a clearer picture of the status of patients potentially affected by COVID-19.
Role of Clinical Informatics During the COVID-19 Pandemic

Never has the crucial role the clinical laboratory plays in the diagnosis and monitoring of patients been more evident than during the current COVID-19 pandemic. Now, more than ever, the laboratory is given the critical responsibility of quickly and efficiently providing insight to providers on the front line to allow for the best management of COVID-19-positive patients.

REMISOL Advance in the Clinical Laboratory

Beckman Coulter’s middleware solution, REMISOL Advance, has been used by many laboratories around the world to enhance efficiency and quality. By consolidating information into a centralized location, laboratory staff can more easily manage patient results.

REMISOL Advance middleware provides patient results from both diagnostic and serology tests on one screen for enhanced laboratory efficiency.

The Value of REMISOL Advance During the COVID-19 Pandemic

In recent weeks, many tests have been developed across a multitude of platforms to help diagnose patients who may or may not have the virus, while others are starting to emerge to identify patients with current or previous exposure to determine the scope with which the virus has impacted the population1. With the help of REMISOL Advance middleware, laboratories can integrate results from cross-functional platforms (Fig 1).

 REMISOL Advance screenshot displaying results across diagnostic disciplines in a single unified view

Figure 1. An example of a patient request in REMISOL Advance, displaying results across diagnostic disciplines in a single, consolidated location. 

When REMISOL Advance is used in conjunction with systems such as Cepheid’s GeneXpert® System and the Beckman Coulter DxI immunoassay analyzer platform, the laboratory can consolidate the view of the results of diagnostic and serological tests for SARS-CoV-2.

Positive Result Reporting to Health Authorities

Laboratories are required to report any positive SARS-CoV-2-related test results to public health authorities in a timely fashion. Utilizing robust reporting capabilities in REMISOL Advance middleware, the laboratory can create a custom list of relevant tests and associated positive results for extraction from the system, allowing simple and seamless reporting to federal agencies without cumbersome manual tracking or queries of laboratory information systems.

Find out how laboratories can fight the Impact of COVID-19 with serology testing.

1U.S. Food and Drug Administration. 2020. Emergency Use Authorizations. [online] Available at: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations [Accessed 5 May 2020].
2Diazyme Laboratories. 2020. Why Do We Need Antibody Tests For COVID-19 And How To Interpret Test Results. [online] Available at: http://www.diazyme.com/covid-19-antibody-tests [Accessed 5 May 2020].
3The critical role of laboratory medicine during coronavirus diseases 2019 (COVID-19) and other viral outbreaks by Giuseppe Lippi and Mario Plebani; Clin Chem Lab Med 2020
4IFCC Information Guide On COVID-19 Tuesday 14 April Updates - IFCC. [online] Ifcc.org. Available at: https://www.ifcc.org/ifcc-news/2020-03-26-ifcc-information-guide-on-covid-19/ [Accessed 5 May 2020].

REMISOL Advance is a trademark or registered trademark of Normand-Info SAS in the United States and other countries. Used under license.

Cepheid, GeneXpert, and Xpert are registered trademarks of Cepheid, its affiliates, or third parties.

Janelle Heysek
Janelle Heysek
Janelle Heysek is the national sales manager for Beckman Coulter’s clinical informatics solutions. She leads the Clinical Informatics team in the technical and strategic positioning of solutions with customers across the United States.

Related Articles

The Need for Efficiency in SARS-CoV-2 Antibody Testing

The Need for Efficiency in SARS-CoV-2 Antibody Testing

Efficiency is an important focus for labs and may be even more important during this pandemic. Learn what features drive efficiency in COVID-19 testing.
Medical Value of SARS-CoV-2 Spike Protein

Medical Value of SARS-CoV-2 Spike Protein

Get high medical value with Access SARS-CoV-2 IgG assay as it detects antibodies against the virus spike protein that may be more likely to confer immunity.
Building a Strong Foundation for Preparedness

Building a Strong Foundation for Preparedness

Find out how organizations can mitigate a pandemic’s interruption of operations and disruption to the provision of critical functions.